...
首页> 外文期刊>European thyroid journal >European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics
【24h】

European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics

机译:欧洲甲状腺关联指南关于甲状腺结节分子细针穿刺细胞学诊断

获取原文
获取原文并翻译 | 示例

摘要

Molecular fine-needle aspiration (FNA) cytology diagnostics has the potential to address the inherent limitation of FNA cytology which is an indeterminate (atypia of undetermined significance/follicular lesion of undetermined significance follicular neoplasm) cytology. Because of the emerging role of molecular FNA cytology diagnostics, the European Thyroid Association convened a panel of international experts to review methodological aspects, indications, results, and limitations of molecular FNA cytology diagnostics. The panel reviewed the evidence for the diagnostic value of mutation panel assessment (including at least BRAF, NRAS, HRAS, KRAS, PAX8/PPARG, RET/PTQ of targeted next generation sequencing and of a microarray gene expression classifier (GEC) test in the diagnostic assessment of an indeterminate cytology thyroid nodule.
机译:分子细针抽吸(FNA)细胞学诊断有可能解决FNA细胞学的固有限制,这是一种不确定的(非典型意义的明显显着性滤窗肿瘤瘤的卵泡病变)细胞学。 由于分子FNA细胞学诊断的新出现作用,欧洲甲状腺协会召开了一个国际专家小组,以审查分子FNA细胞学诊断的方法论方面,适应症,结果和局限性。 该小组审查了突变面板评估诊断价值的证据(包括目标下一代测序的靶向突变,NRA,HRAS,KRA,PAX8 / PPARG,RET / PTQ和微阵列基因表达分类器(GEC)测试 诊断评估不确定细胞学甲状腺结节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号